DNM2 and cancer: The EMT process introduces a malignant phenotype, spindle-shaped morphology, and metastatic functions for cancer cells by altering the activation of transcription factors, expression levels of specific microRNAs and cell-surface proteins, as well as organization of cytoskeletal proteins.